Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcin.2024.06.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of patients undergoing protected high risk percutaneous coronary intervention using either intravascular lithotripsy or rotational atherectomy.
Front Cardiovasc Med
November 2024
Department of Cardiology, Hospital of the Brothers of Mercy Trier, Trier, Germany.
Background: Treating heavily calcified vessels is a challenging task in patients with an impaired left ventricular ejection fraction. Percutaneous mechanical circulatory support (pMCS) is increasingly used in patients in high-risk percutaneous coronary intervention (HRPCI).
Methods: In this retrospective registry, we investigated 25 patients undergoing a protected HRPCI receiving either intravascular lithotripsy (IVL + pMCS; = 11) or rotational atherectomy (RA + pMCS; = 14).
From the valve to the basket: facilitated balloon valvuloplasty for palliative treatment of severe calcified mitral valve stenosis.
Can J Cardiol
December 2024
GMV Care & Research, Maria Cecilia Hospital, Cotignola, Italy.
Mitral annular calcification (MAC) is a chronic degenerative process linked to increased cardiovascular disease and mortality. In patients with degenerative mitral stenosis (DMS), management is typically pharmacological until severe symptoms arise, with surgery often deemed too high-risk. Balloon valvuloplasty has never been a viable option due to the extensive mitral calcifications of DMS anatomies; however, lithotripsy-assisted percutaneous mitral commissurotomy recently emerged as a new alternative for surgery-ineligible patients.
View Article and Find Full Text PDFIntravascular Lithotripsy for common femoral artery occlusive disease.
Ann Vasc Surg
December 2024
Vascular and Endovascular Surgery Department. Cabueñes University Hospital, Gijón, Spain.
Objective: The aim of this study is to assess the safety and feasibility of intravascular lithotripsy (IVL) for the treatment of common femoral artery (CFA).
Methods: We analyzed patients who received IVL treatment for CFA from September 2021 to April 2023. All patients included presented with chronic limb threatening ischemia (CLTI).
Calcified plaque modification during percutaneous coronary revascularization.
Prog Cardiovasc Dis
December 2024
The Christ Hospital Heart & Vascular Institute and The Carl and Edyth Lindner Center for Research and Education, Cincinnati, Ohio, USA.. Electronic address:
The presence and severity of calcified coronary plaque negatively impacts angiographic and clinical outcomes following percutaneous coronary intervention (PCI). Severe coronary calcification is associated with suboptimal stent delivery, deployment, apposition and expansion which can lead to in-stent restenosis and/or thrombosis. Severe coronary calcification is associated with incremental hazard for adverse clinical events, including death, during 5-10 years following PCI despite the use of new generation drug- eluting stents.
View Article and Find Full Text PDFIntravascular lithotripsy prior to transcarotid arterial revascularization: A technical tale of two cases.
SAGE Open Med Case Rep
December 2024
Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
calcific carotid stenosis is becoming more common as the advanced-age population grows, requiring new therapeutic approaches. As such, transcarotid arterial revascularization is gaining significant popularity in the management of carotid stenosis due to low rates of perioperative complications and optimal clinical outcomes. In addition, intravascular lithotripsy has shown promise in safely facilitating the success of endovascular procedures in the context of calcified lesions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!